ABBV R&D Expenses
AbbVie · R&D Expenses
ABBV R&D Expenses
Latest reported$9.71Bperiod ending
ABBV R&D Expenses ($1.71B → $9.71B)
Annual R&D Expenses
High-resolution chart · PNG
ABBV r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 9,096,000,000 | |
| 12,791,000,000 | |
| 7,675,000,000 | |
| 6,510,000,000 | |
| 8,046,000,000 | |
| 7,755,000,000 | |
| 6,792,000,000 | |
| 10,753,000,000 | |
| 5,334,000,000 | |
| 4,585,000,000 | |
| 4,435,000,000 | |
| 3,649,000,000 | |
| 3,193,000,000 | |
| 3,066,000,000 | |
| 3,291,000,000 | |
| 2,808,000,000 | |
| 1,707,440,000 |